Paediatric microbial keratitis prognosis more effective with intensive drug therapy

Article

Early diagnosis, intensive drug therapy, and timely surgical intervention are all associated with the improved prognosis of paediatric microbial keratitis.

Early diagnosis, intensive drug therapy, and timely surgical intervention are all associated with the improved prognosis of paediatric microbial keratitis, states an investigation in the European Journal of Ophthalmology.

Dr Xiusheng Song et al., Department of Ophthalmology, Renmin Hospital of Wuhan University, China, studied the medical records of 80 eyes of 76 children with non-viral microbial keratitis. The outcome measures included demographic features, predisposing factors, clinical features, etiologic microorganisms, and treatment outcomes.

Of the patients studied, 76 met the inclusion criteria. It was found that the most common predisposing factor of microbial keratitis was trauma, with 39 of 80 patients presenting as culture positive. In 21 cases bacterial isolates were found and fungi was found in 19 cases.

Out of the 58 examined eyes, 50 presented with a best-corrected visual acuity of 20/200 or better at the last follow-up. The most frequent bacteria that were isolated were coagulase-negative Staphylococcus.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.